Sep 1, 2026 07:36AM
Aug 10, 2026 04:00PM
Aug 3, 2026 07:00AM
Aug 3, 2026 07:00AM
Jun 12, 2026 07:01AM
Jun 12, 2026 07:00AM
May 7, 2026 04:00PM Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress
Apr 28, 2026 07:00AM
Apr 28, 2026 07:00AM
Mar 27, 2026 03:02PM
Mar 27, 2026 12:00PM
Mar 27, 2026 07:01AM
Mar 27, 2026 07:00AM
Feb 26, 2026 04:00PM Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress
Jan 5, 2026 07:00AM
Dec 9, 2025 11:57AM
Nov 25, 2025 07:00AM
Nov 6, 2025 04:00PM
Oct 14, 2025 07:00AM
Oct 14, 2025 07:00AM
Oct 10, 2025 04:00PM Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 3, 2025 07:06AM
Aug 28, 2025 07:00AM
Aug 21, 2025 06:22AM
Aug 20, 2025 02:11PM
Aug 20, 2025 01:58PM
Aug 20, 2025 07:00AM
Aug 20, 2025 07:00AM Rocket Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on the Pivotal Phase 2 Trial of RP-A501 for the Treatment of Danon Disease
Aug 8, 2025 05:35AM
Aug 7, 2025 04:00PM
Aug 7, 2025 09:25AM
Jul 29, 2025 03:05PM
Jul 25, 2025 06:14AM
Jul 24, 2025 07:00AM
Jul 24, 2025 07:00AM Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs
Jul 22, 2025 05:25PM
Jul 22, 2025 03:51PM
Jul 22, 2025 12:38PM
Jul 20, 2025 04:00PM
Jul 19, 2025 08:05AM
Jul 18, 2025 01:07PM
Jul 18, 2025 12:27PM FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class Action - Hagens Berman
Jul 18, 2025 06:15AM
Jul 17, 2025 07:00AM
Jul 17, 2025 07:00AM
Jul 16, 2025 04:16PM
Jul 15, 2025 08:30AM
Jul 14, 2025 05:11PM
Jul 14, 2025 04:00PM RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jul 14, 2025 12:30PM

329,911 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All